Your browser doesn't support javascript.
loading
[Follow-up of community injecting drug user cohort, 2014-2017].
Luo, W; Kong, J P; Yang, L; Su, M H; Rou, K M; Wu, Z Y.
Afiliación
  • Luo W; Division of Health Education and Prevention and Intervention, National Center for AIDS/STD Control and Prevention, Chinese Center for Diseases Control and Prevention, Beijing 102206, China.
  • Kong JP; Longyang District Center for Diseases Control and Prevention in Baoshan City, Baoshan 678000, China.
  • Yang L; Longyang District Center for Diseases Control and Prevention in Baoshan City, Baoshan 678000, China.
  • Su MH; Longyang District Center for Diseases Control and Prevention in Baoshan City, Baoshan 678000, China.
  • Rou KM; Division of Health Education and Prevention and Intervention, National Center for AIDS/STD Control and Prevention, Chinese Center for Diseases Control and Prevention, Beijing 102206, China.
  • Wu ZY; Division of Health Education and Prevention and Intervention, National Center for AIDS/STD Control and Prevention, Chinese Center for Diseases Control and Prevention, Beijing 102206, China.
Zhonghua Liu Xing Bing Xue Za Zhi ; 40(7): 791-794, 2019 Jul 10.
Article en Zh | MEDLINE | ID: mdl-31357800
ABSTRACT

Objective:

To explore the methods of establishing and maintaining community injecting drug user (IDU) cohort.

Methods:

From June 2014 to June 2017, a community survey was conducted on basis of local needle and syringe exchange site to recruit 200 HIV sero-negative IDU for a prospective cohort study in Longyang district of Baoshan city, Yunan province. Follow-up was carried out every six month to investigate high risk drug use behavior and sexual behavior, and blood samples were collected from them for the tests of HIV and HCV serum antibodies. The cohort would be opened every 12 months to replenish the cohort to 200 subjects.

Results:

The follow up was conducted for 3 years in 229 IDUs. Cohort follow-up rate was 93.0% (213/229) for 6 months, 92.1% (211/229) for 12 months, 91.7% (200/218) for 18 months, 87.2% (190/218) for 24 months, 86.0% (172/200) for 30 months and 86.0% (172/200) for 36 months.

Conclusion:

The community IDU cohort has a high follow-up rate.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Abuso de Sustancias por Vía Intravenosa Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Liu Xing Bing Xue Za Zhi Año: 2019 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Abuso de Sustancias por Vía Intravenosa Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Asia Idioma: Zh Revista: Zhonghua Liu Xing Bing Xue Za Zhi Año: 2019 Tipo del documento: Article País de afiliación: China